This Blueprint Medicines Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

Lake Street analyst Frank Takkinen initiated coverage on Axogen, Inc. AXGN with a Buy rating and announced a price target of $30. Axogen shares closed at $17.25 on Friday. See how other analysts view this stock.
Craig-Hallum analyst John Wilkin initiated coverage on Personalis, Inc. PSNL with a Buy rating and announced a price target of $8. Personalis shares closed at $3.63 on Friday. See how other analysts view this stock.
William Blair analyst Andrew Brackmann initiated coverage on Butterfly Network, Inc. BFLY with an Outperform rating. Butterfly Network shares closed at $2.68 on Friday. See how other analysts view this stock.
Roth MKM analyst Craig Irwin initiated coverage on EZCORP, Inc. EZPW with a Buy rating and announced a price target of $16. EZCORP shares closed at $13.45 on Friday. See how other analysts view this stock.
Jefferies analyst Michael Yee initiated coverage on Blueprint Medicines Corporation BPMC with a Buy rating and announced a price target of $135. Blueprint Medicines shares closed at $89.58 on Friday. See how other analysts view this stock.